Skip to main content

Prospective Influenza Vaccine Safety Surveillance Using Fresh Data in the Sentinel System

Basic Details
Date
Type
Publication
Medical Product
influenza vaccine
Health Outcome(s)
febrile seizure
Description

The Sentinel System can implement a sequential analysis system that uses fresh data for medical product safety surveillance. Active surveillance using sequential analysis of fresh data holds promise for detecting clinically significant health risks early. Limitations of employing fresh data for surveillance include cost and the need for careful scrutiny of signals.

Materials

Pharmacoepidemiology and Drug Safety, 2016, Volume 25, Issue 5, Pages 481–492, DOI: 10.1002/pds.3908

Information
Population / Cohort
All individuals
Related Assessment(s)
Accessing the Freshest Feasible Data for Conducting Active Influenza Vaccine Safety Surveillance (PRISM)
Author(s)

W. Katherine Yih, PhD, MPH, Martin Kulldorff, PhD, Sukhminder K. Sandhu, PhD, MPH, MS, Lauren Zichittella, MS, Judith C. Maro, PhD, MS, David V. Cole, BM, Robert Jin, MS, Alison Tse Kawai, ScD, Meghan A. Baker, MD, ScD, Chunfu Liu, ScD, Cheryl N McMahill-Walraven, PhD, MSW, Mano S. Selvan, PhD, Richard Platt, MD, MSc, Michael Nguyen, MD, Grace M. Lee, MD, MPH

Corresponding Author

W. K. Yih, Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Landmark Center, 401 Park Dr., Suite 401, Boston, MA 02215, USA. E-mail: katherine_yih@harvardpilgrim.org